License Royalties. 3.1 In partial consideration for the license granted by STANFORD to RIGEL under Section 2.1, RIGEL agrees to pay to STANFORD the following: (a) An initial, nonrefundable license issue royalty of [ * ], which amount shall be paid within thirty (30) days after the Effective Date. (b) A royalty payment equal to [ * ] on each of the first three (3) anniversaries of the Effective Date. After the third (3rd) anniversary of the Effective Date, the sublicense shall be considered perpetual and fully paid-up.
Appears in 4 contracts
Samples: License and Research Agreement (Rigel Pharmaceuticals Inc), License and Research Agreement (Rigel Pharmaceuticals Inc), License and Research Agreement (Rigel Pharmaceuticals Inc)
